Andy Levine is co-chair of Jones Day's Corporate Practice, with responsibility for the Firm's Global M&A and Private Equity areas of focus. He has led global transactions, activism defenses, and governance matters for strategic participants and sponsors, including ABM Industries, BioMarin, Bombardier, Brookfield, Cardinal Health, City of Hope, EagleTree Capital, J.F. Lehman & Company, Monster Beverage, Procter & Gamble, Verizon, and WL Ross & Co.
Andy's recent matters include BioMarin's $4.8 billion acquisition of Amicus Therapeutics and its announcement of governance enhancements in 2023; Guess? co-founders' strategic partnership with Authentic Brands Group in a transaction valuing Guess? at $1.4 billion; EagleTree Capital's acquisitions of Nutrail, Summit Hill Foods, MMGY Global, PRA Events, Mackenzie-Childs, and CORSAIR; J.F. Lehman's $5.2 billion consortium acquisition of Atlas Air and its single-asset continuation fund for NorthStar Group; Verizon's $3.3 billion tower prepaid lease transaction with Vertical Bridge and its $3.6 billion sale of datacenter sites to Equinix; Monster Beverage's $3 billion self-tender offer; KKR's acquisition of IVI-RMA; Asbury Automotive Group's $1.45 billion acquisition of Herb Chambers Companies; and Procter & Gamble's $4.2 billion acquisition of Merck KGaA's consumer health business.
He has substantial experience in corporate governance, activism defense, distress M&A, joint ventures, and special committee transactions across a wide range of industries, including pharmaceuticals and health care, consumer goods, telecommunications, real estate, financial services, facility services, advertising and marketing, energy, and manufacturing.
Andy is a frequent author on Delaware law developments, M&A, and governance issues and has appeared as a commentator on CNBC's Squawk Box and Bloomberg.
Expérience
Autres publications
- 2014
Things Are Looking Up: The Outlook for M&A Transactions in 2014, coauthor, Mergers and Acquisitions Law 2014 - 2013
Confidence, Risk, and Reason for Optimism: A Look Ahead at M&A in 2013, coauthor, Mergers and Acquisitions Law 2013 - 2012
Revisiting the Legal Due Diligence Paradigm, coauthor, Inside the Minds: Business Due Diligence Strategies, 2012 ed. - March 2004
Truth and Confidentiality, coauthor, The Daily Deal, Corporate Dealmakers Section - May 2003
Omnicare, coauthor, New York Law Journal
- June 3, 2013
2013 Deutsche Bank M&A Forum
- Boston University (J.D. magna cum laude 1998; Law Review); Northwestern University (B.A. 1994)
- New York
Two-time Private Equity MVP (2016 and 2017) — Law360
40 Under 40 Recognition Award recipient — The M&A Advisor
Editorial board member (PE) — Law360 (2018-2019)
Editorial board member (M&A) — Law360 (2013-2016)
The Legal 500 US — M&A: Large Deals ($1 billion+) and Private Equity